## MOH: Molina Healthcare, Inc. - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_10 at 7.5% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($173.43)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Molina Healthcare of Washington Announces $75,000 Grant to the Seattle Indian Health Board to Support Completion of Thunderbird Treatment Center**
- Source: The AI Journal | 20260106T150816 | Bullish | Relevance: 100%
- Molina Healthcare of Washington, in collaboration with The MolinaCares Accord, has granted $75,000 to the Seattle Indian Health Board for the Thunderbird Treatment Center. This funding will support the completion of the 92-bed residential facility on Vashon Island, which aims to address the disproportionate impact of substance use disorder on tribal and urban Indian communities. The center, set to open in 2026, will offer culturally relevant treatment plans and special programming for parents with young children.

**2. Molina Healthcare of Washington Announces $75,000 Grant to the Seattle Indian Health Board to Support Completion of Thunderbird Treatment Center**
- Source: Business Wire | 20260106T150219 | Bullish | Relevance: 100%
- Molina Healthcare of Washington and The MolinaCares Accord have awarded a $75,000 grant to the Seattle Indian Health Board to help launch the Thunderbird Treatment Center. This 92-bed residential facility on Vashon Island will expand access to culturally relevant treatment for substance use disorder, particularly benefiting Native communities disproportionately affected by the crisis. The new center will nearly double King County's inpatient treatment beds and offer specialized programs for pregnant or parenting adults with young children.

**3. Barclays Raises Price Target for Molina Healthcare (MOH) | MOH S**
- Source: GuruFocus | 20260105T151920 | Neutral | Relevance: 100%
- Barclays has maintained its "Underweight" rating on Molina Healthcare (MOH) but increased its price target from $144 to $164, a 13.89% adjustment. This move reflects recent analyst adjustments, where some firms have lowered price targets while others have maintained ratings. Molina Healthcare, a provider of medical insurance plans predominantly through Medicaid, faces varied analyst perspectives on its market position and future performance.

**4. Merit Financial Group LLC Buys 8,721 Shares of Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20260104T102126 | Neutral | Relevance: 100%
- Merit Financial Group LLC significantly increased its stake in Molina Healthcare (NYSE:MOH) by 289.3% in Q3, adding 8,721 shares to hold a total of 11,735 shares valued at approximately $2.246 million. Despite Molina reporting a Q3 EPS of $1.84, missing consensus estimates, and setting FY2025 guidance at $14.00 EPS, the company maintains a consensus Hold rating and a $196.33 price target from analysts. Other institutional investors also adjusted their positions in MOH during the same period.

**5. Trump eyes a meeting with health insurers “in a few days”**
- Source: Seeking Alpha | 20260106T191423 | Somewhat-Bearish | Relevance: 74%
- President Donald Trump announced plans to meet with representatives from all U.S. insurance companies soon. The purpose of this meeting is to pressure them into lowering healthcare costs for Americans. This initiative aims to address the rising expenses within the healthcare sector.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Barclays | $164 | $144 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Valuation risk: PEG 2.7x with declining EPS estimates leaves no margin for error.
2. Elevated short interest (9.4%): bears positioning against stock.
3. Long-term trend broken: trading 17.0% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.69 signals overvaluation risk, limited margin of safety. Analyst sentiment positive (1 raises, avg +14%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.0B |
| Beta | 0.49 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.69 |
| Forward P/E | 14.8 |
| Current P/E | 13.3 |
| YoY Growth | -10.1% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 3.4% to 7.5% (+4.0% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (7.5% > 6.0%), caution on chasing. MRS_5 at 3.0% confirms short-term momentum alignment. Outperforming sector by 5.8pp, stock-specific strength. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (2.13), confirming momentum. RSI overbought at 79, risk of mean reversion. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.45% (CS: 92) | Strong |
| RSI_14 | 78.7 | Overbought |
| MACD Histogram | 2.13 | Bullish |
| vs SMA20 | 1.108x | Above |
| vs SMA50 | 1.191x | Above |
| vs SMA200 | 0.830x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $184.83
- **Stop Loss:** $173.43 (6.2% risk)
- **Target:** $196.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 115
- **Position Value:** $21,255.45
- **Portfolio %:** 21.26%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*